Journal Mobile Options
Table of Contents
Vol. 24, No. 5, 2007
Issue release date: October 2007
Dement Geriatr Cogn Disord 2007;24:343–347

Relationship between Behavioural and Psychological Symptoms of Dementia and Cognition in Alzheimer’s Disease

Starr J.M. · Lonie J.
aGeriatric Medicine Unit, Royal Victoria Hospital, and bLothian Memory Treatment Service, Jardine Clinic, Royal Edinburgh Hospital, Edinburgh, UK

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Behavioural and psychological symptoms of dementia (BPSDs) are common. It is unclear whether associations are stronger with the absolute cognitive level or that relative to premorbid mental ability. Methods: The Neuropsychiatric Inventory (NPI) was administered to carers of patients with Alzheimer’s disease (AD). Patients underwent cognitive testing with the National Adult Reading Test (NART) to estimate premorbid IQ and 6 tests of current cognitive function. Results: 556 patients, mean age 77.3 years, had NPI scores. The total NPI score correlated significantly with most cognitive test scores, but multi-linear regression identified NART-IQ as the only significant cognitive predictor (β = –0.17, p = 0.008). Principal component analysis of the 10 NPI domains extracted 3 components corresponding to mood, frontal and psychotic factors. The NPI mood factor correlated significantly with NART-IQ (ρ = –0.14, p = 0.014) and lexical verbal fluency (ρ = –0.09, p = 0.034) only. The NPI frontal factor correlation with NART-IQ approached significance (ρ = –0.11, p = 0.053). The NPI psychotic factor correlated significantly with the Mini-Mental State Examination (ρ = –0.15, p < 0.001) and the Hopkins verbal learning test (ρ = –0.11, p = 0.013) scores. Conclusion: The relationship between BPSDs and cognition in AD is weak and largely explained by premorbid IQ. There is a stronger relationship between current cognition and psychotic symptoms.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC: Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000;157:708–714.
  2. Chung JA, Cummings JL: Neurobehavioral and neuropsychiatric symptoms in Alzheimer’s disease: characteristics and treatment. Neurol Clin 2000;18:829–846.
  3. Spalletta G, Baldinetti F, Buccione I, Fadda L, Perri R, Scalmana S, Serra L, Caltagirone C: Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer’s disease. J Neurol 2004;251:688–695.
  4. Srikanth S, Nagaraja AV, Ratnavalli E: Neuropsychiatric symptoms in dementia – frequency, relationship to dementia severity and comparison in Alzheimer’s disease, vascular dementia and frontotemporal dementia. J Neurol Sci 2005;236:43–48.
  5. Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Hashimoto M, Yamashita H: Factors associated with psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1998;64:648–652.
  6. Piccininni MP, Di Carlo A, Baldereschi M, Zaccara G, Inzitari D: Behavioral and psychological symptoms in Alzheimer’s disease: frequency and relationship with duration and severity of disease. Dement Geriatr Cogn Disord 2005;19:276–281.
  7. Porter VR, Buxton WG, Fairbanks LA, Strickland T, O’Connor SM, Rosenberg-Thompson S, Cummings JL: Frequency and characteristics of anxiety among patients with Alzheimer’s disease and related dementias. J Neuropsychiatry Clin Neurosci 2003;15:180–186.
  8. Lyketsos CG, Sheppard JME, Steinberg M, Tschanz JA, Norton MC, Steffens DC, Breitner JC: Neuropsychiatric disturbance in Alzheimer’s disease clusters into three groups: the Cache County study. Int J Ger Psychiatr 2001;16:1043–1053.
  9. Frisoni GB, Rozzini L, Gozzetti A, Binetti G, Zanetti O, Bianchetti A, Trabucchi M, Cummings JL: Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Disord 1999;10:130–138.
  10. Starr JM, Lonie J: The influence of pre-morbid IQ on Mini-mental State Examination score at time of dementia presentation. Int J Geriatr Psychiatry 2007;22:382–384.
  11. Starr JM: Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer disease. J Am Geriatr Soc 2007;55:800-801.
  12. Nelson HE: The National Adult Reading Test (NART): Test Manual. Windsor, NFER-Nelson, 1982.
  13. McGurn B, Starr JM, Topfer JA, Pattie A, Whiteman MC, Lemmon HA, Whalley LJ, Deary IJ: Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation. Neurology 2004;62:1184–1186.
  14. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  15. Brandt J: The Hopkins verbal learning test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991;5:125–142.
  16. Lezak MD: Neuropsychological Assessment (ed 3). Oxford, Oxford University Press, 1995.
  17. Robbins T, James M, Owen A, Sahakian BJ, McInnes L, Rabbitt P: Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large number of normal elderly volunteers. Dementia 1994;5:266–281.
  18. Cummings JL, Mega MS, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
  19. Aalten P, de Vugt ME, Lousberg R, Korten E, Jaspers N, Senden B, Jolles J, Verhey FR: Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord 2003;15:99–105.
  20. Richards M, Deary IJ: A life course approach to cognitive reserve: a model for cognitive aging and development. Ann Neurol 2005;58:617–622.
  21. Blennow K, de Leon MJ, Zetterberg H: Alzheimer’s disease. Lancet 2006;368:387–403.
  22. Bain GH, Lemmon H, Teunisse S, Starr JM, Fox HC, Deary IJ, Whalley LJ: Quality of life in healthy old age: relationships with childhood IQ, minor psychological symptoms and optimism. Soc Psychiatry Psychiatr Epidemiol 2003;38:632–636.
  23. Meins W, Frey A, Thiesemann R: Premorbid personality traits in Alzheimer’s disease: do they predispose to noncognitive behavioral symptoms? Int Psychogeriatrics 1998;10:369–378.
  24. Starr JM, Loeffler B, Abousleiman Y, Simonotto E, Marshall I, Goddard N, Wardlaw JM: Episodic and semantic memory tasks activate different brain regions in Alzheimer’s disease. Neurology 2005;65:266–269.
  25. Shenkin SD, Bastin ME, MacGillivray TJ, Deary IJ, Starr JM, Wardlaw JM: Childhood and current cognitive function in healthy 80-year-olds: a DT-MRI study. Neuroreport 2003;14:345–349.
  26. Chow TW, Liu CK, Fuh JL, Leung VP, Tai CT, Chen LW, Wang SJ, Chiu HF, Lam LC, Chen QL, Cummings JL: Neuropsychiatric symptoms of Alzheimer’s disease differ in Chinese and American patients. Int J Geriatr Psychiatry 2002;17:22–28.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50